See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.

A high-level overview of Gilead Sciences, Inc. (GILD) stock. View (GILD) real-time stock price, chart, news, analysis, analyst reviews and more.

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Review quarterly and annual revenue, net income, and cash flow for Gilead Sciences Inc (GILD:XNAS) stock through the last fiscal year.

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

Integration has its challenges and drawbacks, but, if successful, Portugal can act as a gateway to significant opportunities, sources say.

PURPOSEWe investigated breastfeeding patterns, behaviors, and association with breast cancer (BC) outcomes in women with early hormone receptor–positive (HR+) BC who had a live birth in the POSITIVE ...